Summary : This figure illustrates the relationship between hemoglobin (Hb) level and oxygen delivery in individuals with sickle cell disease (SCD), highlighting the optimal Hb range for oxygen transport in SCD compared to normal individuals. line plot: # Title & Axes : • No explicit title on the plot, but the context is "Relationship between hemoglobin level and oxygen delivery in individuals with SCD." • X-axis: "Hemoglobin" (units not specified, but contextually g/dL). • Y-axis: "Oxygen delivery" (units not specified). • X-axis tick labels: 10, 15, 20. • Y-axis: No tick labels, only qualitative trend. # Data Points & Series : • Single red curve showing oxygen delivery as a function of hemoglobin level. • The curve rises from Hb = 10, peaks near Hb = 14–16, then declines toward Hb = 20. • Arrow and annotation for "Sickle Cell Anemia Hb_max ~10–11" indicating the optimal Hb range for SCD. • Dashed vertical line at "Normal Hb_max ~14–16" indicating the optimal Hb range for normal individuals. # Design Encodings : • Red solid line for the main curve. • Yellow arrow highlighting the SCD optimal Hb range. • Dashed vertical line for normal Hb_max. • Text annotations for "Sickle Cell Anemia Hb_max ~10–11" and "Normal Hb_max ~14–16". # Distribution & Trends : • The curve is unimodal, peaking at intermediate Hb levels. • Oxygen delivery increases with Hb up to a point, then decreases at higher Hb levels. • The optimal Hb for SCD is lower (~10–11 g/dL) than for normal individuals (~14–16 g/dL). # Analysis : • The figure visually demonstrates that the maximal oxygen delivery in SCD occurs at a lower hemoglobin level than in normal individuals, due to altered red cell viscosity and oxygen transport in SCD. • Increasing Hb above the SCD optimal range may decrease oxygen delivery, while lowering Hb to the optimal range can improve oxygen transport. • The curve supports clinical recommendations for transfusion targets in SCD patients to avoid excessive Hb levels that could impair oxygen delivery.

This diagnostic image set displays two functional MR images (A and B) showing maternal-fetal units in a mouse model at embryonic days 14.5 and 17.5. The images feature overlaid color-coded AP50 maps, which represent fetal and placental oxygen-hemoglobin dissociation parameters. In both panels, the placenta and fetal liver are isolated as regions of interest. A vertical color bar on the right side indicates AP50 values scaled from 0 to 1.0, with cool colors (dark blue) representing lower values and warm colors (red/orange) representing higher values. Panel A (day 14.5) demonstrates a heterogeneous distribution of oxygenation parameters within the tissues, showing a mix of green, yellow, and blue pixels. Panel B (day 17.5) illustrates the progression of these physiological markers over time, with the placental AP50 values showing a significant spatial shift toward warmer colors, reflecting changes in oxygen transfer efficiency. These maps provide a non-invasive visual method for studying fetal oxygenation and placental function during gestation.

This physiological data visualization consists of three stacked line graphs (A, B, and C) depicting the relationship between inspired oxygen concentration (FIO2) and hemoglobin oxygen saturation over time in a cyclic hypoxia-reoxygenation model. The horizontal x-axis represents time in seconds (0 to 250s). Each graph features dual y-axes: the left axis measures 'Oxygen saturation of haemoglobin (%)' from 40% to 100%, represented by a black line; the right red axis measures 'FIO2 (%)' from 0% to 25%, represented by a red line. The graphs demonstrate physiological response to progressively longer hypoxic phases (15s, 20s, 30s, and 40s) across four cycles. Graph A shows mild hypoxia (FIO2 12%), Graph B shows moderate hypoxia (FIO2 9%), and Graph C shows severe hypoxia (FIO2 6%). Key clinical concepts illustrated include the latency period between FIO2 changes and hemoglobin desaturation, the nadir of saturation proportional to FIO2 severity, and the incomplete resaturation occurring when normoxic intervals are insufficient. These records provide a representative look at respiratory physiology and gas exchange dynamics during intermittent hypoxia.

A clinical photograph illustrating a patient performing a Pulmonary Function Test (PFT) via spirometry in a clinical or research setting. The image depicts an older adult male seated upright, wearing a nose clip to ensure mouth-only breathing. He is actively interacting with a handheld spirometer, holding the disposable mouthpiece with both hands to maintain a tight seal. The device is connected via a data cable to a computer system, which includes a monitor displaying an active interface, likely for real-time visualization of flow-volume loops and spirograms. On the desk, several replacement white cylindrical mouthpieces and the hardware interface are visible. This visual serves as an educational example of the standardized setup for measuring lung volumes and ventilation capacities, such as Forced Vital Capacity (FVC) and Forced Expiratory Volume in 1 second (FEV1), highlighting the necessary equipment and proper patient positioning during the procedure.

This composite of clinical photographs illustrates three standard methods for assessing physical performance and physiological capacity in a laboratory setting. Top Left: A participant undergoes maximal isometric strength measurement using an arm extension dynamometer. The subject is seated with the upper limb secured to a mechanical lever arm equipped with force transducers to quantify torque and muscular exertion. Top Right: A measurement of pulmonary function (spirometry) is shown. The participant uses a handheld spirometer with a nose clip to ensure isolated oral airflow, measuring lung volumes and capacities such as FVC and FEV1. Bottom: The participant is engaged in an anaerobic capacity assessment via a Wingate anaerobic test. This involves high-intensity cycling on a specialized ergometer to measure peak power, anaerobic fatigue, and total anaerobic work. These tests are essential in sports medicine and exercise physiology for evaluating cardiovascular fitness, neuromuscular strength, and metabolic efficiency.

**Imaging Modality:** Lung Scintigraphy (V/Q Scan) **Anatomical Region:** Bilateral lungs, thoracic cavity. **Observed Pathology:** The image demonstrates a classic ventilation-perfusion (V/Q) mismatch. The perfusion scan (right panel) reveals multiple large, wedge-shaped, segmental photopenic areas indicating significant perfusion defects throughout both lung fields. Conversely, the ventilation scan (left panel) shows relatively homogeneous tracer distribution without corresponding filling defects. **Characteristic Visual Features:** * **Perfusion Scan:** Multi-focal areas of absent or diminished radiopharmaceutical uptake, particularly noted in the middle and lower zones of the right lung and the mid-zone of the left lung. * **Ventilation Scan:** Preserved ventilation across both lung fields, contrasting with the perfusion irregularities. * **Pattern:** Non-matched defects, where ventilation is normal in areas of absent perfusion. **Clinical Context and Diagnostic Features:** This V/Q mismatch pattern is highly suggestive of pulmonary embolism (PE). The presence of multiple segmental perfusion defects in the setting of normal ventilation is the primary diagnostic criterion for a "high probability" lung scan for thromboembolic disease. These findings allow for the differentiation from obstructive lung diseases, which typically present with matched V/Q defects.

**Imaging Modality:** Ventilation-Perfusion (V/Q) Lung Scintigraphy / SPECT-CT Fusion image. **Anatomical Region:** Bilateral thoracic cavity and lungs. **Observed Pathology:** The image demonstrates a significant ventilation-perfusion mismatch localized to the left lung. While the right lung shows relatively homogeneous and preserved tracer distribution, the left lung exhibits a large, segmental, wedge-shaped area of absent or severely diminished perfusion in the lower lobe and mid-lung zones. **Characteristic Visual Features:** - **Right Lung:** Normal tracer uptake appearing as green-to-yellow pseudo-coloring, indicating balanced ventilation and perfusion. - **Left Lung:** A distinct "cold zone" or photopenic area is visible in the lower two-thirds of the lung field, represented by a dark/purple-black void against the functional tracer. This indicates a profound perfusion deficit. - **Distribution:** The deficit is peripheral and follows a segmental distribution, characteristic of vascular occlusion. **Key Diagnostic Features:** The presence of a V/Q mismatch—characterized by preserved lung volume/structure but focal absence of blood flow—is a primary scintigraphic hallmark of pulmonary embolism or significant pulmonary arterial obstruction. The image highlights the functional disparity between the two hemithoraces.

This composite educational graphic combines a line chart and four serial chest radiographs illustrating the correlation between lung compliance and radiographic improvement in a pediatric patient. The line graph at the top tracks pulmonary compliance (ml/cmH2O) over five days (Day 11 to Day 15), showing a steady upward trend interrupted by transient dips following medical interventions. Four supine anteroposterior (AP) chest X-rays correspond to specific time points. Image (a) on Day 11 shows bilateral hazy opacities, particularly on the right, suggesting pulmonary edema or consolidation. Image (b) on Day 12 reveals a persistent right-sided opacity prior to lavage and hematoma removal. Image (c) on Day 13 shows improved lung volumes and increased radiolucency before surfactant administration. Image (d) on Day 15 demonstrates significantly improved aeration with clear costophrenic angles and visible pulmonary vasculature, correlating with the highest recorded compliance levels on the graph. The presence of medical devices, including an endotracheal tube and monitors, indicates critical care management, likely during ECMO support.

This composite educational image illustrates the effects of different surfactant treatments on pulmonary function and morphology in a premature rabbit model of Respiratory Distress Syndrome (RDS). Panel A is a line graph showing tidal volumes (ml/kg) over a 30-minute ventilation period across four groups: rSP-C33Leu surfactant (orange), Phospholipids (blue), Poractant alfa (green), and no treatment (yellow). Panel B is a scatter plot depicting lung gas volumes (ml/kg) at the end of ventilation, showing median values for the same experimental groups. Panel C features four macroscopic clinical photographs of excised lungs from each treatment group. The photographs visually compare lung expansion and aeration: lungs treated with Poractant alfa and rSP-C33Leu appear lighter, pinker, and more uniformly inflated, whereas lungs from the 'no treatment' and 'phospholipids' groups appear darker, more congested, and exhibit significant atelectasis (collapse). This infographic serves to demonstrate the therapeutic efficacy of recombinant SP-C based synthetic surfactants in improving lung compliance and gas exchange compared to phospholipid-only controls.